Originally posted by danwiththeplan
View Post
Unconfigured Ad
Collapse
X
-
Well, my understanding was that spike-ins (ERCC spike ins like this: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166838/) allow you to control for effects that would otherwise go undetected between runs (gc content, length effects, concentration effects), whether those runs are biological or technical reps, and that spike-ins would allow you to detect these effects from the point that they are spiked in (which should be as soon as possible), so, they are useful for validating all of the steps from that point onwards (i.e. polyA purification, ribodepletion, library construction). But maybe I misunderstood and I'm open to being corrected.Originally posted by HESmith View PostActually, no. Spike-ins are only useful for validating the reproducibility of library construction (i.e., technical replicates). They tell you nothing about how much transcript levels vary b/t samples (biological replicates).
Plus, I'm not sure why anyone would do technical reps anyway when there's so much more value to be gained from another biological rep.Last edited by danwiththeplan; 03-14-2013, 01:59 PM.
Comment
-
Okay, my answer was clearly too terse. When RNA-Seq data indicate a difference in gene expression, there are two potential causes: biological (i.e., transcript levels go up or down in the cell/tissue/organism), and technical (changes introduced on the path from nucleic acid isolation to sequence generation). Spike-in controls are useful for detecting/validating the points you mention, but those are all technical aspects of the experiment. Spike-ins do contribute to the biological basis for the observed difference, but only in the sense of eliminating technical bias as the culprit.
Comment
-
Yep. Well put.Originally posted by HESmith View PostOkay, my answer was clearly too terse. When RNA-Seq data indicate a difference in gene expression, there are two potential causes: biological (i.e., transcript levels go up or down in the cell/tissue/organism), and technical (changes introduced on the path from nucleic acid isolation to sequence generation). Spike-in controls are useful for detecting/validating the points you mention, but those are all technical aspects of the experiment. Spike-ins do contribute to the biological basis for the observed difference, but only in the sense of eliminating technical bias as the culprit.
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
17 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment